Deformation of Silica Aerogel During Fluid Adsorption

Aerogels are very compliant materials - even small stresses can lead to large deformations. In this paper we present measurements of the linear deformation of high porosity aerogels during adsorption of low surface tension fluids, performed using a Linear Variable Differential Transformer (LVDT). We show that the degree of deformation of the aerogel during capillary condensation scales with the surface tension, and extract the bulk modulus of the gel from the data. Furthermore we suggest limits on safe temperatures for filling and emptying low density aerogels with helium.Comment: 8 pages, 5 figures, submitted to PR

Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial

Background Third-generation aromatase inhibitors are more effective than tamoxifen for preventing recurrence in postmenopausal women with hormone-receptor-positive invasive breast cancer. However, it is not known whether anastrozole is more effective than tamoxifen for women with hormone-receptor-positive ductal carcinoma in situ (DCIS). Here, we compare the efficacy of anastrozole with that of tamoxifen in postmenopausal women with hormone-receptor-positive DCIS. Methods In a double-blind, multicentre, randomised placebo-controlled trial, we recruited women who had been diagnosed with locally excised, hormone-receptor-positive DCIS. Eligible women were randomly assigned in a 1:1 ratio by central computer allocation to receive 1 mg oral anastrozole or 20 mg oral tamoxifen every day for 5 years. Randomisation was stratified by major centre or hub and was done in blocks (six, eight, or ten). All trial personnel, participants, and clinicians were masked to treatment allocation and only the trial statistician had access to treatment allocation. The primary endpoint was all recurrence, including recurrent DCIS and new contralateral tumours. All analyses were done on a modified intention-to-treat basis (in all women who were randomised and did not revoke consent for their data to be included) and proportional hazard models were used to compute hazard ratios and corresponding confidence intervals. This trial is registered at the ISRCTN registry, number ISRCTN37546358. Results Between March 3, 2003, and Feb 8, 2012, we enrolled 2980 postmenopausal women from 236 centres in 14 countries and randomly assigned them to receive anastrozole (1449 analysed) or tamoxifen (1489 analysed). Median follow-up was 7·2 years (IQR 5·6–8·9), and 144 breast cancer recurrences were recorded. We noted no statistically significant difference in overall recurrence (67 recurrences for anastrozole vs 77 for tamoxifen; HR 0·89 [95% CI 0·64–1·23]). The non-inferiority of anastrozole was established (upper 95% CI <1·25), but its superiority to tamoxifen was not (p=0·49). A total of 69 deaths were recorded (33 for anastrozole vs 36 for tamoxifen; HR 0·93 [95% CI 0·58–1·50], p=0·78), and no specific cause was more common in one group than the other. The number of women reporting any adverse event was similar between anastrozole (1323 women, 91%) and tamoxifen (1379 women, 93%); the side-effect profiles of the two drugs differed, with more fractures, musculoskeletal events, hypercholesterolaemia, and strokes with anastrozole and more muscle spasm, gynaecological cancers and symptoms, vasomotor symptoms, and deep vein thromboses with tamoxifen. Conclusions No clear efficacy differences were seen between the two treatments. Anastrozole offers another treatment option for postmenopausal women with hormone-receptor-positive DCIS, which may be be more appropriate for some women with contraindications for tamoxifen. Longer follow-up will be necessary to fully evaluate treatment differences

Spherical porous carbon particles derived from suspensions and sediments of resorcinol-formaldehyde particles

The goal of this study is the completion of the parameter field of resorcinol–formaldehyde solutions towards the regime of non-monolithic phases. For low sodium carbonate concentration and low mass content of resorcinol and formaldehyde in the starting solution the formation of spherical particles rather than monolithic gels is observed. The organic precursors were converted into carbon powders by pyrolysis. The resulting carbon particles were characterized by scanning electron microscopy (SEM), nitrogen sorption and small-angle X-ray scattering (SAXS). The study shows that carbonization of the organic particles results in spherical carbon particles with a micropore volume of about 0.28 cm3/g. The composition of the starting solution, however, strongly affects the external surface area as determined from sorption data for the organic as well as for the corresponding carbon particles; the values derived can be converted into average diameters of spherical particles ranging from 30 nm to 5 μm. Complementary SEM and SAXS measurements confirm these findings. A diameter of 5 μm appears to be the upper size limit in particle size forming, while 30 nm spheres develop near the formation of a continuous gel at relatively high sodium carbonate concentrations